Christopher & Banks Corporation (CBK) stock price moved 21.42% away from 20-Days Simple Moving Average, 10.49% from 50-Days Simple Moving Average and separated -35.52% from 200 Days Simple Moving Average. Christopher & Banks Corporation (CBK) reported gain 4.38% in recent buying and selling session with closing price of $ 0.52. The stock’s traded 0.24 million shares in session while it holds an average volume of 0.26 million shares. The CBK switched 70.72% away from its 52 week minimum and distanced -61.91% from its 52 week peak. The volatility change in the previous week has observed by 7.87% and experienced of 14.79% change in the last month.
The short ratio in the company’s stock is documented at 11.15 and the short float is around of 7.75%. Beta factor, which measures the riskiness of the security, was registered at 2.56. The Company kept a record of 37.04 million floated shares and 37.60 million shares outstanding. The average true range of the stock is observed at 0.06 and the relative strength index of the stock is recorded at 60.00.
Christopher & Banks Corporation (CBK) Stock Profitability Levels:
Net profit margin of the company is seen at -8.50%. Operating profit margin is positioned at -8.70%. Gross profit margin is 29.30%. The larger the gross profit margin, the better for the company. The company made Return on equity of -71.60% in last 12 months period. Return on assets ratio of the Company was -26.70%. Its return on investment ratio was -43.40% in the trailing 12 months period.
The Company’s sales have grown at an average annualized rate of about -3.20% during the past five years. For the past 5 years, The Company’s EPS growth has been nearly -5.60%. Looking out over a next 5-year period, analysts expect the company to see its earnings go up by 44.30%, annually. Analyst established EPS growth expected to grow of -23.20% for this year and EPS growth for next year is likely to attain at 47.10%.
Looking about the past performance history, the company jumped 1.38% for the last five trades and expanded 44.37% in one month period. The stock deteriorated -25.44% during the past three month period and discounted -48.33% in half year. During the yearly overview it downgraded -59.23% and shown 12.19% year to date performance.